Education
About Us
Working with TipRanks
Follow Us
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
Mineralys Therapeutics, Inc. (MLYS) Ownership Overview
42.32% Insiders
7.79% Mutual Funds
0.59% Other Institutional Investors
10.34% ETFs
38.96% Public Companies and
Individual Investors
The ownership structure of Mineralys Therapeutics, Inc. (MLYS) stock is a mix of institutional, retail, and individual investors. Approximately 18.72% of the company’s stock is owned by Institutional Investors, 42.32% is owned by Insiders, and 38.96% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Sep 08, 2025 | xxxxxxxxxxxxx | $29999985 | |
Sep 08, 2025 | xxxxxxxxxxxxx | $14999993 | |
Jul 30, 2025 | xxxxxxxxxxxxx | $1077243 | |
Apr 25, 2025 | xxxxxxxxxxxxx | $3499997 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2025 | xxxxxxxxxxxxx | $1188854 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,903,838 | Insider | 11.48% | 330,332,390 | |
| 7,323,750 | Insider | 9.44% | 271,711,125 | |
| 6,263,151 | Insider | 8.07% | 232,362,902 | |
| 6,147,280 | Institution | 7.92% | 228,064,088 | |
| 5,674,916 | Insider | 7.32% | 210,539,384 | |
| 2,899,020 | Institution | 3.74% | 107,553,642 | |
| 1,996,921 | Institution | 2.57% | 74,085,769 | |
| 1,844,001 | Institution | 2.38% | 68,412,437 | |
| 1,805,585 | Institution | 2.33% | 66,987,204 | |
| 946,747 | Institution | 1.22% | 35,124,314 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,899,020 | Institution | 3.74% | 107,553,642 | |
| 1,805,585 | Institution | 2.33% | 66,987,204 | |
| 738,891 | Institution | 0.95% | 27,412,856 | |
| 663,430 | Institution | 0.86% | 24,613,253 | |
| 645,332 | Institution | 0.83% | 23,941,817 | |
| 373,226 | Institution | 0.48% | 13,846,685 | |
| 324,189 | Institution | 0.42% | 12,027,412 | |
| 301,700 | Institution | 0.39% | 11,193,070 | |
| 169,004 | Institution | 0.22% | 6,270,048 | |
| 97,577 | Institution | 0.13% | 3,620,107 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,210,076 | Institution | 1.56% | 17,122,575 | |
| 976,538 | Institution | 1.26% | 36,229,560 | |
| 724,327 | Institution | 0.93% | 26,915,991 | |
| 402,703 | Institution | 0.52% | 5,698,247 | |
| 349,498 | Institution | 0.45% | 12,966,376 | |
| 245,707 | Institution | 0.32% | 9,115,730 | |
| 223,275 | Institution | 0.29% | 8,296,899 | |
| 186,533 | Institution | 0.24% | 2,639,442 | |
| 182,261 | Institution | 0.23% | 6,761,883 | |
| 157,741 | Institution | 0.20% | 5,861,656 |
FAQ
Who Owns Mineralys Therapeutics, Inc. (MLYS)?
According to the latest TipRanks data, approximately 0.59% of the company's stock is held by institutional investors, 42.32% is held by insiders, and 38.96% is held by retail investors.
What percentage of Mineralys Therapeutics, Inc. (MLYS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.59% of Mineralys Therapeutics, Inc. (MLYS) stock is held by institutional investors.
What percentage of Mineralys Therapeutics, Inc. (MLYS) stock is held by retail investors?
According to the latest TipRanks data, approximately 38.96% of Mineralys Therapeutics, Inc. (MLYS) stock is held by retail investors.
Who owns the most shares of Mineralys Therapeutics, Inc. (MLYS)?
Brian Taylor Slingsby owns the most shares of Mineralys Therapeutics, Inc. (MLYS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.